Enovis (ENOV) Total Debt Growth (3y) (2013 - 2026)
Powered by 
Analysis
Enovis (ENOV) Total Debt Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.40 Bn | 175.80 Bn | 7.27 Bn | 24.63% |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.21 Bn | 108.39 Bn | 6.34 Bn | 4.06% |
| 4 | Stryker | 105.12 Bn | 101.64 Bn | 4.50 Bn | 4.89% |
| 5 | Boston Scientific | 64.52 Bn | 63.98 Bn | 3.85 Bn | 11.72% |
| 6 | Edwards Lifesciences | 49.95 Bn | 45.69 Bn | 1.35 Bn | 0.11% |
| 7 | Alcon | 33.09 Bn | 31.63 Bn | 1.68 Bn | 252.76% |
| 8 | Dexcom | 32.17 Bn | 30.23 Bn | 830.00 Mn | - |
| 9 | Steris | 20.75 Bn | 20.27 Bn | 684.20 Mn | -10.56% |
| 10 | Enovis | 1.08 Bn | 1.07 Bn | 359.25 Mn | 48.95% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 48.95% |
| Apr 3, 2026 | 68.40% |
| Dec 31, 2025 | 40.66% |
| Oct 3, 2025 | 15.37% |
| Jul 4, 2025 | 16.29% |
| Apr 4, 2025 | -17.34% |
| Dec 31, 2024 | -13.62% |
| Sep 27, 2024 | -5.93% |
| Jun 28, 2024 | -5.63% |
| Mar 29, 2024 | -22.66% |
| Dec 31, 2023 | -40.90% |
| Sep 29, 2023 | -43.97% |
| Jun 30, 2023 | -43.97% |
| Mar 31, 2023 | -51.94% |
| Dec 31, 2022 | -41.08% |
| Sep 30, 2022 | -39.52% |
| Jul 1, 2022 | -39.98% |
| Apr 1, 2022 | -16.68% |
| Dec 31, 2021 | 20.31% |
| Oct 1, 2021 | 12.62% |